Randomized Clinical Trials That Advance Health and Health Equity JAMA Internal Medicine Call for Papers

Randomized clinical trials (RCTs) provide the highest level of evidence that shape patient care, guideline recommendations, performance benchmarks, and health care coverage decisions. JAMA Internal Medicine is issuing a call for RCTs that advance health and health equity by studying the efficacy and/or effectiveness of clinical, policy, and public health approaches. We are interested in publishing traditional individual-level, parallel group RTCs, aswell as studies using other randomization approaches, such as Bayesian adaptive, cluster-randomization, stepped-wedge, crossover, and waitlist designs.